Ocular Toxoplasmosis in Tropical Areas: Analysis and Outcome of 190 Patients from a Multicenter Collaborative Study

REFERENCES

• Bonfioli AA, Orefice F. Toxoplasmosis. Semin Ophthalmol. 2005;20(3):129–141.
   PubMedGoogle Scholar
• Jones JL, Kruszon-Moran D, Wilson M, McQuillan G, Navin T, McAuley JB. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am J Epidemiol. 2001;154(4):357–365.
   PubMed Web of Science ®Google Scholar
• Glasner PD, Silveira C, Kruszon-Moran D, et al. An unusually high prevalence of ocular toxoplasmosis in southern Brazil. Am J Ophthalmol. 1992;114(2):136–144.
   PubMed Web of Science ®Google Scholar
• Holland GN, Lewis KG. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 2002;134(1):102–114.
   PubMed Web of Science ®Google Scholar
• Silveira C, Belfort R, Muccioli C, et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol. 2002;134(1):41–46.
   PubMed Web of Science ®Google Scholar
• Bosch-Driessen LE, Berendschot TTJM, Ongkosuwito JV, Rothova A. Ocular toxoplasmosis: clinical features and prognosis of 154 patients. Ophthalmology. 2002;109(5):869–878.
   PubMed Web of Science ®Google Scholar
• Tufail A, Holland GN. Ocular Infection and Immunity. St. Louis: Mosby;1996. 1183.
   Google Scholar
• Ongkosuwito JV, Bosch-Driessen EH, Kijlstra A, Rothova A. Serologic evaluation of patients with primary and recurrent ocular toxoplasmosis for evidence of recent infection. Am J Ophthalmol. 1999;128(4):407–412.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. Sep, 2005;140(3):509–516.
   PubMed Web of Science ®Google Scholar
• Nussenblatt RB, Palestine AG, Chan -C-C, Roberge F. Standardization of vitreal inflammatory activity in intermediate and posterior uveitis. Ophthalmology. 1985;92(4):467–471.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Freeman K, Lago EG, et al. Ocular Sequelae of Congenital Toxoplasmosis in Brazil Compared with Europe. PLoS Negl Trop Dis. 2008;2(8):e277. doi:10.1371/journal.pntd.0000277.
   PubMed Web of Science ®Google Scholar
• Dodds EM, Holland GN, Stanford MR, et al. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol. 2008;146(6):856–865.e2.
   PubMed Web of Science ®Google Scholar
• Vallochi AL, Muccioli C, Martins MC, Silveira C, Belfort R, Rizzo LV. The genotype of Toxoplasma gondii strains causing ocular toxoplasmosis in humans in Brazil. Am J Ophthalmol. 2005;139(2):350–351.
   PubMed Web of Science ®Google Scholar
• Shobab L, Pleyer U, Johnsen J, et al. Toxoplasma serotype is associated with development of ocular toxoplasmosis. J Infect Dis. 2013;208(9):1520–1528.
   PubMed Web of Science ®Google Scholar
• Bottos J, Miller RH, Belfort RN, Macedo AC, Belfort R, Grigg ME. Bilateral retinochoroiditis caused by an atypical strain of Toxoplasma gondii. Br J Ophthalmol. 2009;93:1546–1550.
   PubMed Web of Science ®Google Scholar
• Lehmann T, Marcet PL, Graham DH, Dahl ER, Dubey JP. Globalization and the population structure of Toxoplasma gondii. Proc Natl Acad Sci U S A. 2006;103:11423–11428.
   PubMed Web of Science ®Google Scholar
• Shwab EK, Zhu X-Q, Majumdar D, et al. Geographical patterns of Toxoplasma gondii genetic diversity revealed by multilocus PCR-RFLP genotyping. Parasitology. 2014;141(4):453–461. doi:10.1017/s0031182013001844.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Stanford MR, Jackson H, Holliman RE, Sanders MD. Incidence of acute symptomatic Toxoplasma retinochoroiditis in south London according to country of birth. Br Med J. 1995;310:1037–1040.
   PubMedGoogle Scholar
• Paivonsalo-Hietanen T, Tuominen J, Matti Saari K. Uveitis in children: population-based study in Finland. Acta Ophthalmol Scand. 2000;78:84–88.
   PubMedGoogle Scholar
• Smith RE, Ganley JP. Ophthalmic survey of a community. Abnormalities of the ocular fundus. Am J Ophthalmol. 1972;74:1126–1130.
   PubMed Web of Science ®Google Scholar
• Maetz HM, Kleinstein RN, Federico D, Wayne J. Estimated prevalence of ocular toxoplasmosis and toxocariasis in Alabama. J Infect Dis. 1987;156:414.
   PubMed Web of Science ®Google Scholar
• de-la-Torre A, González G, Díaz-Ramirez J, Gómez-Marín JE. Screening by ophthalmoscopy for Toxoplasma retinochoroiditis in Colombia. Am J Ophthalmol. 2007;143:354–356.
   PubMed Web of Science ®Google Scholar
• Petersen E, Kijlstra A, Stanford M. Epidemiology of ocular toxoplasmosis. Ocul Immunol Inflamm. 2012;20:68–75.
   PubMed Web of Science ®Google Scholar
• Carellos EV, Caiaffa WT, Andrade GMQ, Abreu MNS, Januário JN. (2013) Congenital toxoplasmosis in the state of Minas Gerais, Brazil: a neglected infectious disease? Epidemiol Infect. Mar, 2014;142(3):644–655.
   PubMed Web of Science ®Google Scholar
• Population Trends. Page 3. Department of Statistics. Singapore: 2014. ISSN 1793-2424 www.singstat.gov.sg
   Google Scholar
• Jones JL, Dargelas V, Roberts J, Press C, Remington J, Montoya J. Risk factors for Toxoplasma gondii infection in the United States. Clin Infect Dis. Sep, 15 2009;49(6):878–884.
   PubMed Web of Science ®Google Scholar
• Singh S, Munawwar A, Rao S, Mehta S, Hazarika NK, Ghedin E. Serologic prevalence of Toxoplasma gondii in Indian women of child bearing age and effects of social and environmental factors. PLoS Negl Trop Dis. 2014;8:e2737. doi:10.1371/journal.pntd.0002737.
   PubMed Web of Science ®Google Scholar
• Dupey JP, Lago EG, Gennari SM, Su C, Jones JL. Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology. Parasitology. 2012;139(11):1375–1424. doi:10.1017/S0031182012000765.
   PubMed Web of Science ®Google Scholar
• Gilbert RE, Dunn DT, Lightman S, et al. Incidence of symptomatic toxoplasma eye disease: aetiology and public health implications. Epidemiol Infect. 1999;123(2):283–289.
   PubMed Web of Science ®Google Scholar
• Montoya JG, Remington JS. Toxoplasmic chorioretinitis in the setting of acute acquired toxoplasmosis. Clin Infect Dis. 1996;23(2):277–282.
   PubMed Web of Science ®Google Scholar
• Veeranoot Nissapatorn. Toxoplasmosis: A Silent Threat in Southeast Asia. Res J Parasitol. 2007;2(1):1–12.
   Google Scholar
• Miles RS. Antibiotics for toxoplasmic retinochoroiditis: an evidence-based systemic review. Ophthalmology. 2003;111(3):610–611.
   Google Scholar
• Rothova A. Ocular involvement in Toxoplasmosis. Br J Ophthalmol. 1993;77:371–377.
   PubMed Web of Science ®Google Scholar
• Garweg JG, Stanford MR. Therapy for ocular toxoplasmosis–the future. Ocul Immunol Inflamm. 2013;21(4):300–305.
   PubMed Web of Science ®Google Scholar
• Rothova A, Meenken C, Buitenhuis HJ, et al. Therapy for ocular toxoplasmosis. Am J Ophthalmol. Apr, 15 1993;115(4):517–523.
   PubMed Web of Science ®Google Scholar
• de-la-Torre A, Sauer A, Pfaff AW, et al. Severe South American ocular toxoplasmosis is associated with decreased Ifn-γ/Il-17a and increased Il-6/Il-13 intraocular levels. PLoS Negl Trop Dis. Nov, 21 2013;7(11):e2541.
   PubMed Web of Science ®Google Scholar